Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Nakamura

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|December 15, 2005
Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouseKazuhiro Araki, Takafumi Sangai, Shin'ichi Miyamoto, et al.
Nephron. Clinical Practice|April 25, 2009
Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney diseaseTatsuya Suwabe, Yoshifumi Ubara, Yasushi Higa, et al.
Journal of Bone and Mineral Metabolism|November 12, 2010
Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomyJunji Yamauchi, Yoshifumi Ubara, Tatsuya Suwabe, et al.
BMC Cancer|May 7, 2022
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, et al.
Acta Oncologica (Stockholm, Sweden)|May 5, 2012
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancerYoshito Komatsu, Satoshi Yuki, Susumu Sogabe, et al.
Journal of Bone and Mineral Metabolism|March 4, 2009
A case of primary hyperparathyroidism with severe bone and renal changesRika Jimbo-Saito, Yoshifumi Ubara, Hiraku Kadoguchi, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
Prognosis of patients on continuous ambulatory peritoneal dialysis (CAPD) for over 10 yearsTakafumi Toyohara, Yoshifumi Ubara, Yasushi Higa, et al.
Internal Medicine (Tokyo, Japan)|December 22, 2012
Parathyroid hemorrhage occurring after administration of cinacalcet in a patient with secondary hyperparathyroidismMotonori Nagasawa, Yoshifumi Ubara, Tatsuya Suwabe, et al.
Clinical Calcium|November 8, 2005
[Case of autosomal dominant polycystic kidney disease associated with pelvic insufficiency fracture]Yasushi Higa, Yoshifumi Ubara, Tetsuo Tagami, et al.
The Oncologist|March 18, 2022
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)Yasuyuki Kawamoto, Satoshi Yuki, Takashi Meguro, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|December 15, 2005
Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouseKazuhiro Araki, Takafumi Sangai, Shin'ichi Miyamoto, et al.
Nephron. Clinical Practice|April 25, 2009
Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney diseaseTatsuya Suwabe, Yoshifumi Ubara, Yasushi Higa, et al.
Journal of Bone and Mineral Metabolism|November 12, 2010
Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomyJunji Yamauchi, Yoshifumi Ubara, Tatsuya Suwabe, et al.
BMC Cancer|May 7, 2022
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, et al.
Acta Oncologica (Stockholm, Sweden)|May 5, 2012
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancerYoshito Komatsu, Satoshi Yuki, Susumu Sogabe, et al.
Journal of Bone and Mineral Metabolism|March 4, 2009
A case of primary hyperparathyroidism with severe bone and renal changesRika Jimbo-Saito, Yoshifumi Ubara, Hiraku Kadoguchi, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
Prognosis of patients on continuous ambulatory peritoneal dialysis (CAPD) for over 10 yearsTakafumi Toyohara, Yoshifumi Ubara, Yasushi Higa, et al.
Internal Medicine (Tokyo, Japan)|December 22, 2012
Parathyroid hemorrhage occurring after administration of cinacalcet in a patient with secondary hyperparathyroidismMotonori Nagasawa, Yoshifumi Ubara, Tatsuya Suwabe, et al.
Clinical Calcium|November 8, 2005
[Case of autosomal dominant polycystic kidney disease associated with pelvic insufficiency fracture]Yasushi Higa, Yoshifumi Ubara, Tetsuo Tagami, et al.
The Oncologist|March 18, 2022
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)Yasuyuki Kawamoto, Satoshi Yuki, Takashi Meguro, et al.
Pageof 12